Clinical Trials Sponsored by Galderma R&D

Total 1119 results

PepsiCo Global R&D

Completed

Glycemic and Insulinemic Response to Oats Soaked Overnight in Milk Compared to Cream of Rice in Healthy Subjects

Glycemic, Insulinemic, Subjective Appetite Responses

Canada
Janssen R&D Ireland

Completed

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection

Chronic Hepatitis C | Genotype 4 Chronic Hepatitis C

Spain
Vernalis (R&D) Ltd

Completed

Study of the Safety, Tolerability and Efficacy of V3381 in Patients With Diabetic Peripheral Neuropathic Pain

Diabetic Peripheral Neuropathic Pain

United States, United Kingdom, Canada, Czech Republic
Janssen R&D Ireland

Completed

TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin Therapy (ATTAIN)

Hepatitis C

United States, Australia, France, Poland, United Kingdom, Germany, Spain, Belgium, Israel, Portugal, Bulgaria, Romania, Denmark, Greece, Sweden, Canada, Czech Republic, Argentina, Brazil, Austria, Hungary, Switzerland, Puerto Rico, No...
Janssen R&D Ireland

Completed

A Study to Evaluate the Safety, Tolerability, and Effectiveness of a 12-Week Combination Therapy of TMC647055 and TMC435 With and Without GSK23336805 With a Pharmacokinetic Enhancer With and Without Ribavirin in Patients Infected With Chronic Genotype 1 Hepatitis C Virus

Chronic Hepatitis C

Belgium, Germany
Janssen R&D Ireland

Completed

An Efficacy, Pharmacokinetics, Safety and Tolerability Study of TMC435 as Part of a Treatment Regimen for Hepatitis C-Infected Patients

Hepatitis C, Chronic

China, Korea, Republic of
PepsiCo Global R&D

Completed

Effect of Oats on Lipid Profile

Mildly Hypercholesterolemic Subjects
Janssen R&D Ireland

Completed

A Study to Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1

Hepatitis C Virus Genotype-1

United States, France, United Kingdom, Germany, Spain, Portugal, Canada, Puerto Rico
PepsiCo Global R&D

Unknown

Plant Based Extracts and Cognition (CEOPTB)

Change in Cognitive Function and Fatigue During Extended Performance of the Cognitive Demand Battery (CDB) at 1, 3 and 6 Hours Post Consumption | Change in Long Term Declarative Memory at 1, 3 and 6 Hours Post-intervention.

United Kingdom
Janssen R&D Ireland

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2336805 Alone and With the Co-administration of TMC435 in Healthy Japanese Participants.

Healthy

United States
Janssen R&D Ireland

Completed

An Efficacy, Safety, and Tolerability Study of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Participants (QUEST-2)

Hepatitis C

United States, France, Poland, Belgium, Germany, Spain, Portugal, Bulgaria, Turkey, Argentina, Brazil, Austria, Netherlands, Slovakia, Puerto Rico
Newtricious R&D BV

Completed

Effect of NWT-03 on Blood Pressure

Blood Pressure | Albuminuria

Ireland
Janssen R&D Ireland

Terminated

Study in HCV-Infected Patients to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of JNJ-47910382

Chronic Hepatitis C Infection

Germany
Janssen R&D Ireland

Completed

A Study to Explore the Pharmacokinetics of Rilpivirine With Rifabutin in Healthy Participants

Healthy

Belgium
Janssen R&D Ireland

Completed

Study to Examine Multiple Doses of TMC647055 in Combination With Telaprevir

Hepatitis C

Germany
Janssen R&D Ireland

Completed

TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients

HIV Infections | Acquired Immunodeficiency Syndrome

United States, France, Argentina, South Africa, Thailand
Janssen R&D Ireland

Completed

A Study to Compare the Bioavailability of JNJ-47910382 Formulated as a Tablet and as Suspension in Healthy Participants

Healthy Participants

Belgium
Janssen R&D Ireland

Completed

A Study to Assess Bioavailability & Food Effect of Different Liquid and Capsule Formulations of TMC435.

Healthy Volunteers

United Kingdom
Janssen R&D Ireland

Completed

A Study to Assess the Bioequivalence of Darunavir When Co-Administrated With Cobicistat Under Fed and Fasted Conditions

Healthy Participants

Belgium
Janssen R&D Ireland

Completed

A Study in Healthy Participants Investigating the Safety, Tolerability and Plasma Pharmacokinetics (PK) of Single Oral Doses of JNJ-47910382

Hepatitis C Virus Infection

Germany
Vernalis (R&D) Ltd

Completed

Single and Multiple Ascending Dose Study of V158866 in Healthy Volunteers

First in Man Study

United Kingdom
Vernalis (R&D) Ltd

Completed

A Clinical Trial to Find Out V81444's Side Effects and Blood Levels in Healthy Men

Parkinson's Disease

United Kingdom
Vernalis (R&D) Ltd

Completed

Safety and Efficacy of Low Doses of V24343 in Obese Subjects

Obesity

United Kingdom
PepsiCo Global R&D

Recruiting

Exploring the Relationship Between Heart Rate Variability (HRV), Training Load, and Exercise Performance

Exercise | Heart Rate Variability

United States
Unilever R&D
Intertek

Completed

Evaluation of the Effect of Zinc Citrate Trihydrate Toothpaste on the Oral Plaque Microbiome

Dental Plaque
PepsiCo Global R&D

Completed

A Prospective, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy of Bacillus Coagulans Unique IS2 on Improving Bowel Movement Characteristics, Gastrointestinal-related Symptoms and Quality of Life in Healthy Adult Participants

Stool Frequency

Canada
SocraTec R&D GmbH

Completed

Rivastigmine Bioequivalence Trial With Multiple Applications of Transdermal Patches (9.5 mg/24 h)

Bioequivalence

Germany
PepsiCo Global R&D

Completed

Investigating the Efficacy of Low or High Dose Tart Cherry on Recovery From Exercise Induced Muscle Damage and Establishing Its Molecular Mechanisms of Action

Muscle Recovery

United Kingdom
PepsiCo Global R&D

Completed

Guayusa: The Effect of an Herbal Extract on Alertness and Mental Fatigue

Attention Difficulties

United States
PepsiCo Global R&D

Completed

Acute Effects of Mango Leaf Extract on Cognitive Function in Healthy Adults: A Double-Blind, Placebo-Controlled Crossover Study

Mood | Cognition | Attention

United Kingdom
PepsiCo Global R&D

Completed

Acute and Chronic Effect of 250 mg Citicoline Consumption on Attention in Adults: A Randomized Trial

Attention

United States
PepsiCo Global R&D

Completed

Validity of Smart Cap and Smart Sweat Patch

Fluid Intake in Athletes | Sweating Rate in Athletes | Sweat Chloride Concentration in Athletes

United States
PepsiCo Global R&D

Completed

NBA G-League Sweat Testing Study: Validity of the Gx Sweat Patch in Measuring Sweating Rate and Sweat Chloride Concentration During On-court Training With Basketball Players

Sweat Analysis

United States
Janssen R&D Ireland

Completed

Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected Participants

Human Immunodeficiency Virus Type 1

United States, France, United Kingdom, Belgium, Spain, Switzerland, Sweden, Canada, Puerto Rico, Poland
PepsiCo Global R&D

Completed

Effect of Protein-nutrition Beverages on Muscle Protein Synthesis in Women

Muscle Protein Synthesis

Canada
PepsiCo Global R&D

Completed

Sweat Patch Validation

Sweat Analysis

United States
PepsiCo Global R&D

Terminated

Liking Adaptation to Beverages of Varying Sweetness Levels After Prolonged Exposure

Sweetness Liking Adaptation

United States
PepsiCo Global R&D

Completed

Dose Effect of a Plant Extract on Fatigue

Mental Energy | Physical Performance

United States
PepsiCo Global R&D

Completed

Effect of Added Fruit Pomace Fiber, Juice, and Whole Fruit on Postprandial Glycemia

Glycemic Index

United States
PepsiCo Global R&D

Completed

Supplementary Food for Moderate Acute Malnutrition in Children

Moderate Acute Malnutrition

Mexico
PepsiCo Global R&D

Completed

Nutrients to Enhance Sleep Quality and Quantity

Sleepiness in Athletes
PepsiCo Global R&D

Completed

The Impact of Acute (2 h) and Short-term (4 Days) Nitrate Supplementation in the Form of Red Beet Root Juice on Intense Intermittent Exercise Performance.

Exercise Performance

United Kingdom
PepsiCo Global R&D

Completed

The Effect of Dietary Nitrate Supplementation on Linear Running Sprint Performance, Agility and Vertical Jump Performance in a Rested and Fatigued State

Exercise Performance
PepsiCo Global R&D

Completed

Four-hour Glycemic Kinetic Response Following 13C-enriched Oatmeal Breakfast Compared to Hot Corn Grits

Glycemic and Insulinemic Response

Canada
Vernalis (R&D) Ltd

Completed

Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD)

ADHD

United States
Vernalis (R&D) Ltd

Completed

Safety and Efficacy Study in Acute Ischaemic Stroke (VASST)

Stroke

United States, Canada
Vernalis (R&D) Ltd

Completed

A Study in Healthy Male Volunteers to Investigate a New Drug for the Treatment of Parkinson's Disease

Parkinson's Disease
Janssen R&D Ireland

Completed

A Study of TMC435 in Combination With Peginterferon Alfa-2A and Ribavirin for Hepatitis C Virus Genotype-1 Infected Patients Who Participated in a Control Group of a TMC435 Study

Hepatitis C

United States, Australia, France, Ukraine, United Kingdom, Belgium, Germany, Spain, Israel, Portugal, Bulgaria, Netherlands, Canada, New Zealand, Russian Federation, Argentina, Brazil, Puerto Rico, Austria, Poland, Romania, Mexico
Janssen R&D Ireland

Completed

A Study in Japanese Children Hospitalized With Respiratory Syncytial Virus Related Lower Respiratory Tract Infections

Respiratory Syncytial Virus

Japan
PepsiCo Global R&D

Completed

An Observational Pilot Study to Characterize Relationships Between Self-reported Information, Game Performance, and Passive Physiology Measures Throughout a Daily Cycle

Energy and Cognition

3

Subscribe